ASCO and UICC collaborate to extend reach of Journal of Global Oncology

28 August 2015

The American Society of Clinical Oncology (ASCO) and the Union for International Cancer Control (UICC) partner to expand the reach of the Journal of Global Oncology (JGO)

The American Society of Clinical Oncology (ASCO) and the Union for International Cancer Control (UICC) announced today their partnership to expand the reach of the Journal of Global Oncology (JGO), a new open-access journal that will focus on cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. 

It is estimated that today nearly two-thirds of all cancer deaths occur in low- and middle-income countries (LMICs), and this is forecast to increase to 70 percent by 20301. While some journals publish special issues and sections focused on global oncology, JGO will be the first peer-reviewed journal dedicated solely to this area of research. 

The partnership between ASCO, which boasts more than 35,000 members around the world, and UICC, whose membership represents more than 800 organisations in 155 countries, will extend the reach of the Journal to a broad international audience. ASCO and UICC will work together to solicit high-quality original research, secure funding, and promote the Journal to their respective networks

Through this collaboration, ASCO and UICC will meet a growing need for high-quality clinical cancer research in LMICs by providing a peer-review platform focused on the challenges faced by researchers and care providers in these countries. 

"ASCO is committed to conquering cancer through research, education, prevention and delivery of high quality patient care, and this aligns closely with UICC's efforts to unite the cancer community to reduce the global cancer burden," said David Kerr, MD, DSc, JGO's founding Editor in Chief. "This partnership will amplify the impact of the Journal of Global Oncology in support of both organisations' missions, and will give a voice to those clinicians who practice cancer medicine in challenging conditions."

The Journal of Global Oncology is funded through the Conquer Cancer Foundation of the American Society of Clinical Oncology with the support of the Doris Duke Charitable Foundation and Novartis Oncology.

1International Agency for Research on Cancer, GLOBOCAN, 2012 

About ASCO
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit Patient-oriented cancer information is available at Cancer.Net.

About the Union for International Cancer Control (UICC)
UICC unites the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda. UICC is the largest cancer-fighting organisation of its kind, with over 800 member organisations across 155 countries representing the world's major cancer societies, ministries of health, research institutes, treatment centres and patient groups. Together with its members and multisectoral partners, UICC is tackling the growing cancer crisis on a global scale. For more information, please visit

Last update: 
Wednesday 19 July 2017